PHARMACODYNAMICS OF SINGLE DOSES OF PRORENOATE POTASSIUM AND SPIRONOLACTONE IN FLUDROCORTISONE TREATED NORMAL SUBJECTS

被引:18
作者
RAMSAY, LE [1 ]
SHELTON, JR [1 ]
TIDD, MJ [1 ]
机构
[1] GD SEARLE & CO LTD,DIV SCI AFFAIRS,HIGH WYCOMBE HP12 4HL,BUCKINGHAMSHIRE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1976.tb00624.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:475 / 482
页数:8
相关论文
共 23 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS
[2]  
EDMONDS CJ, 1960, LANCET, V1, P505
[3]  
GANTT CL, 1963, METABOLISM, V12, P1007
[4]  
Giebisch G., 1971, KIDNEY, V3, P329
[5]   FLUOROHYDROCORTISONEAND CHLOROHYDROCORTISONE, HIGHLY POTENT DERIVATIVES OF COMPOUND-F [J].
GOLDFIEN, A ;
LAIDLAW, JC ;
HAYDAR, NA ;
RENOLD, AE ;
THORN, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 1955, 252 (11) :415-421
[6]  
HERMAN TS, 1968, J BIOL CHEM, V243, P3849
[7]   ALDOSTERONE - REVIEW OF ITS PHYSIOLOGY AND DIAGNOSTIC ASPECTS OF PRIMARY ALDOSTERONISM [J].
HORTON, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1973, 22 (12) :1525-1545
[8]  
JICK H, 1963, METABOLISM, V12, P381
[10]  
KAGAWA CM, 1964, EVALUATION DRUG ACT, V2, P745